INC Research (NASDAQ:SYNH) was downgraded by stock analysts at TheStreet from a “b-” rating to a “c” rating in a research note issued on Monday, December 18th.
A number of other research analysts have also recently issued reports on the stock. Mizuho assumed coverage on shares of INC Research in a report on Thursday, September 21st. They set a “neutral” rating and a $57.00 price objective for the company. Zacks Investment Research upgraded shares of INC Research from a “hold” rating to a “buy” rating and set a $58.00 price objective for the company in a report on Wednesday, September 27th. Robert W. Baird reiterated a “buy” rating and set a $67.00 price objective on shares of INC Research in a report on Monday, October 9th. Jefferies Group upgraded shares of INC Research from a “hold” rating to a “buy” rating and lifted their price objective for the company from $62.50 to $69.00 in a report on Monday, October 9th. Finally, Credit Suisse Group assumed coverage on shares of INC Research in a report on Wednesday, October 11th. They set an “outperform” rating and a $68.00 price objective for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $50.78.
Shares of INC Research (SYNH) traded up $0.10 during midday trading on Monday, reaching $42.20. 589,329 shares of the company were exchanged, compared to its average volume of 1,149,980. INC Research has a fifty-two week low of $33.60 and a fifty-two week high of $61.10. The company has a market capitalization of $8,700.00, a P/E ratio of -74.04, a PEG ratio of 1.25 and a beta of 1.09. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.27 and a quick ratio of 1.27.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://stocknewstimes.com/2018/01/11/thestreet-downgrades-inc-research-incr-to-c.html.
INC Research Company Profile
Syneos Health, Inc, formerly INC Research Holdings, Inc, is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research and related companies with MarketBeat.com's FREE daily email newsletter.